Cargando…

Incidence of Epstein-Barr virus reactivation is elevated in COVID-19 patients

COVID-19, an infectious respiratory illness, is caused by infection with the SARS-CoV-2 virus. Individuals with underlying medical conditions are at increased risk of developing serious illnesses such as long COVID. Recent studies have observed Epstein-Barr virus (EBV) reactivation in patients with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bernal, Keishanne Danielle E., Whitehurst, Christopher B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10292739/ https://www.ncbi.nlm.nih.gov/pubmed/37364815 http://dx.doi.org/10.1016/j.virusres.2023.199157

Ejemplares similares

REACTIVATION OF EPSTEIN-BARR VIRUS AND CYTOMEGALOVIRUS INFECTION IN PATIENTS WITH COVID-19
por: ALMAGUER, ANGELICA, et al.
Publicado: (2022)

Prevalence of Epstein–Barr Virus Genotypes in Pakistani Lymphoma Patients
por: Salahuddin, Sadia, et al.
Publicado: (2018)

Valpromide Inhibits Lytic Cycle Reactivation of Epstein-Barr Virus
por: Gorres, Kelly L., et al.
Publicado: (2016)

High incidence of Epstein–Barr virus, cytomegalovirus, and human-herpes virus-6 reactivations in critically ill patients with COVID-19
por: Simonnet, A., et al.
Publicado: (2021)

Stress-Induced Epstein-Barr Virus Reactivation
por: Sausen, Daniel G., et al.
Publicado: (2021)

Epstein–Barr Virus and Human Herpesvirus-6 Reactivation in Acute COVID-19 Patients
por: Brooks, Bailey, et al.
Publicado: (2022)

Elevated Levels of Interferon-γ Are Associated with High Levels of Epstein-Barr Virus Reactivation in Patients with the Intestinal Type of Gastric Cancer
por: Cárdenas-Mondragón, María G., et al.
Publicado: (2017)

Low incidence and morbidity of Epstein‐Barr virus reactivation following donor lymphocyte infusions
por: Martinovic, Danilo, et al.
Publicado: (2023)

Inhibition of Epstein-Barr virus reactivation by the flavonoid apigenin
por: Wu, Chung-Chun, et al.
Publicado: (2017)

Epstein-Barr Virus Reactivation Causing Cholestatic Hepatitis
por: Da Cunha, Teresa, et al.
Publicado: (2022)

Epstein-Barr Virus Coinfection in COVID-19
por: Nadeem, Asim, et al.
Publicado: (2021)

Investigation of Long COVID Prevalence and Its Relationship to Epstein-Barr Virus Reactivation
por: Gold, Jeffrey E., et al.
Publicado: (2021)

Epstein–Barr Virus Infection Is Associated with Elevated Hepcidin Levels
por: Duque, Ximena, et al.
Publicado: (2023)

Clinical characteristics and outcomes of critically ill patients with acute COVID-19 with Epstein-Barr virus reactivation
por: Xie, Yun, et al.
Publicado: (2021)

Anticonvulsant Hypersensitivity Syndrome Associated with Epstein-Barr Virus Reactivation
por: Chang, Jae Yong, et al.
Publicado: (2007)

Association between Epstein‐Barr‐Virus reactivation and development of Long‐COVID fatigue
por: Rohrhofer, Johanna, et al.
Publicado: (2022)

Potential Cellular Functions of Epstein-Barr Nuclear Antigen 1 (EBNA1) of Epstein-Barr Virus
por: Smith, Danielle Westhoff, et al.
Publicado: (2013)

The Epstein-Barr Virus
por: Payne, L. N.
Publicado: (1980)

PANDAS/PANS in the COVID-19 Age: Autoimmunity and Epstein–Barr Virus Reactivation as Trigger Agents?
por: Pallanti, Stefano, et al.
Publicado: (2023)

Epstein–Barr virus serology and gastric cancer incidence and survival
por: Koshiol, J, et al.
Publicado: (2007)

Pre-Emptive Use of Rituximab in Epstein–Barr Virus Reactivation: Incidence, Predictive Factors, Monitoring, and Outcomes
por: Papalexandri, Apostolia, et al.
Publicado: (2023)

Knockout of Epstein-Barr Virus BPLF1 Retards B-Cell Transformation and Lymphoma Formation in Humanized Mice
por: Whitehurst, Christopher B., et al.
Publicado: (2015)

Epstein - Barr virus Pneumonitis
por: McManus, Terence E, et al.
Publicado: (2009)

Epstein-Barr virus and nasopharyngeal carcinoma
por: Young, Lawrence S., et al.
Publicado: (2014)

A Molecular Link between Malaria and Epstein–Barr Virus Reactivation
por: Chêne, Arnaud, et al.
Publicado: (2007)

Epstein–Barr Virus Reactivation-Induced Immunoglobulin Production: Significance on Autoimmunity
por: Nagata, Keiko, et al.
Publicado: (2020)

Molecular Basis of Epstein–Barr Virus Latency Establishment and Lytic Reactivation
por: Murata, Takayuki, et al.
Publicado: (2021)

Epstein–Barr virus reactivation‐related meningoencephalitis with transverse myelitis in pregnancy
por: Nguyen, Andrew Dang Khai, et al.
Publicado: (2023)

Epstein–Barr virus and cytomegalovirus coinfection in Egyptian COVID-19 patients
por: Barakat, Eman F, et al.
Publicado: (2023)

Inhibition of Epstein-Barr Virus Lytic Reactivation by the Atypical Antipsychotic Drug Clozapine
por: Anderson, Abbie G., et al.
Publicado: (2019)

Epstein–Barr virus vaccines
por: Cohen, Jeffrey I
Publicado: (2015)

Epstein–barr virus vaccines
por: Cohen, Jeffrey I
Publicado: (2015)

Epstein-Barr virus and skin
por: Sangueza-Acosta, Martin, et al.
Publicado: (2018)

Epstein-Barr Virus Gastritis
por: Oki, Masayuki, et al.
Publicado: (2017)

Resurrecting Epstein–Barr Virus
por: Paganelli, Roberto
Publicado: (2022)

Elevated Antibody Titers to Epstein–Barr Virus and Cytomegalovirus in Patients with Drug-Induced Lupus
por: Knudsen, Julie, et al.
Publicado: (2023)

Characteristics of Epstein–Barr virus reactivation after allogeneic haematopoietic stem cell transplantation in patients with chronic active Epstein–Barr virus disease: favorable responses to rituximab
por: Wei, Na, et al.
Publicado: (2021)

Epstein–Barr virus-associated lymphomas
por: Shannon-Lowe, Claire, et al.
Publicado: (2017)

Reactivation of Epstein–Barr Virus Presenting as Massive Splenomegaly after Initiation of Golimumab Treatment
por: Febres-Aldana, Anthony J., et al.
Publicado: (2020)

Epstein-Barr Virus Genome Deletions in Epstein-Barr Virus-Positive T/NK Cell Lymphoproliferative Diseases
por: Wongwiwat, Wiyada, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_26afgf6gvklt8vsvsvtvo1m1kn